Dubin-Johnson syndrome is a rare, inherited liver condition that causes recurring or persistent jaundice, the yellowing of the skin and eyes, because the liver cannot properly excrete a form of bilirubin into bile. It follows an autosomal recessive inheritance pattern, meaning a person needs to inherit a defective copy of the responsible gene from each parent to develop the condition. Despite the visible jaundice, it is considered benign: people with Dubin-Johnson syndrome generally have a normal life expectancy and rarely need any treatment beyond reassurance and monitoring.
What Goes Wrong Inside the Liver
Bilirubin is a yellowish waste product that forms when old red blood cells break down. The liver processes it by attaching sugar molecules to it, creating what is called conjugated bilirubin, which is then pumped into bile and eventually leaves the body through the intestines. In Dubin-Johnson syndrome, the pump responsible for that last step is missing or broken.
That pump is a protein called MRP2, encoded by the ABCC2 gene. When this gene carries certain mutations, MRP2 either never makes it to the cell membrane where it needs to work or arrives there in a nonfunctional state. Research on specific mutations has shown that some cause the protein to fold incorrectly, leading to its destruction inside the cell before it can reach the surface, while others allow the protein to reach the membrane but leave it unable to move its cargo across it.1PubMed. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2) One well-studied mutation, R768W, disrupts the protein’s maturation and sorting so it never reaches its proper position, whereas a different mutation, Q1382R, lets the protein arrive at the membrane but cripples its ability to use energy to push substrates through.2PubMed. Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome
The practical result is the same regardless of which mutation a person carries: conjugated bilirubin backs up in the liver and spills over into the bloodstream, producing jaundice. The liver itself also accumulates a dark, melanin-like pigment over time, turning the organ a distinctive brownish-black color that is visible during biopsy or surgery.
Signs and Symptoms
The hallmark of Dubin-Johnson syndrome is jaundice that comes and goes or persists at a low level. In most people, it is mild enough that the yellowing of the eyes (called scleral icterus) is more noticeable than yellowing of the skin. Blood tests show elevated conjugated (also called direct) bilirubin, while other liver function tests such as enzymes and albumin are typically normal.3PubMed Central. Clinical characteristics and ABCC2 genotype in Dubin-Johnson syndrome – Section: Abstract
Many people with the condition go years without a diagnosis because the jaundice is so mild or intermittent that it does not prompt medical attention. Episodes of more visible jaundice can be triggered by intercurrent illness, physical stress, fasting, or hormonal changes. Pregnancy and oral contraceptive use are well-recognized triggers in women, presumably because estrogen metabolites compete for the same impaired excretion pathway. Some individuals also report vague abdominal discomfort or fatigue during flares, though it is not always clear whether these symptoms come from the syndrome itself or from anxiety about the visible jaundice.
How It Is Diagnosed
Diagnosing Dubin-Johnson syndrome can be straightforward once a clinician thinks of it, but the challenge is thinking of it in the first place. A young, otherwise healthy person with isolated elevated conjugated bilirubin and normal liver enzymes should raise suspicion. Several tools help confirm the diagnosis.
Urinary Coproporphyrin Pattern
One of the most reliable non-invasive clues comes from a urine test. In Dubin-Johnson syndrome, total urinary coproporphyrin excretion stays within the normal range, but more than 80 percent of it is excreted as coproporphyrin isomer I rather than isomer III. In healthy individuals, isomer III predominates. This reversal happens because impaired MRP2 function forces isomer I back into the bloodstream and out through the kidneys instead of into bile.4PubMed Central. Rotor Syndrome Presenting as Dubin-Johnson Syndrome – Section: Discussion The test is particularly useful because it helps distinguish Dubin-Johnson from Rotor syndrome, a different inherited jaundice that looks similar on standard blood work.
Cholescintigraphy
A nuclear medicine scan called cholescintigraphy (often using a tracer known as Tc-99m HIDA) produces a characteristic image in Dubin-Johnson syndrome. The liver takes up the tracer intensely and holds onto it for a prolonged period, appearing bright and homogeneous on the scan, while the gallbladder and bile ducts either show up late or not at all.5PubMed. 99mTc-HIDA cholescintigraphy in Dubin-Johnson and Rotor syndromes The same pattern has been confirmed in children with the syndrome.6PubMed. 99mTc-HIDA cholescintigraphy in children with Dubin-Johnson syndrome This scan is not routinely ordered for every patient, but it can be helpful when the clinical picture is ambiguous.
Liver Biopsy and Genetic Testing
A liver biopsy in Dubin-Johnson syndrome reveals the characteristic dark pigment deposited in liver cells. The pigment is coarsely granular and concentrated around the bile canaliculi. While biopsy was once considered important for confirmation, genetic testing of the ABCC2 gene has increasingly replaced it, especially as new pathogenic variants continue to be identified.7PubMed Central. Clinical characteristics and ABCC2 genotype in Dubin-Johnson syndrome – Section: Abstract Genetic testing is non-invasive and definitive when a known mutation is found.
Telling It Apart from Rotor Syndrome
Rotor syndrome is the condition most often confused with Dubin-Johnson syndrome because both produce conjugated hyperbilirubinemia in otherwise healthy individuals. However, the two arise from completely different transport defects and can be distinguished by a few key features.
In Rotor syndrome, the problem is not with pumping bilirubin out of the liver cell but with re-absorbing it after it has briefly escaped back into the blood. Rotor syndrome results from combined deficiencies of two uptake transporters, OATP1B1 and OATP1B3, on the blood-facing side of the liver cell.8Journal of Clinical and Translational Hepatology. Dubin-Johnson and Rotor Syndromes: A Review and Update of Pathophysiological Mechanisms – Section: Abstract Because bilirubin is not re-captured after its initial handling, it circulates longer and is filtered out by the kidneys in larger amounts, leading to higher total urinary coproporphyrin excretion. Importantly, in Rotor syndrome the fraction of isomer I is elevated but not to the extreme degree seen in Dubin-Johnson syndrome.
The liver itself also looks different. In Rotor syndrome there is no dark pigment accumulation, so the liver appears normal on biopsy or during surgery. In Dubin-Johnson syndrome the striking black pigmentation is essentially diagnostic.9Journal of Clinical and Translational Hepatology. Dubin-Johnson and Rotor Syndromes: A Review and Update of Pathophysiological Mechanisms – Section: Abstract On cholescintigraphy, Rotor syndrome typically shows faint or absent liver uptake of the tracer, the opposite of the intense uptake seen in Dubin-Johnson syndrome.
Where It Is Most Common
Dubin-Johnson syndrome is rare worldwide, but it clusters in certain populations due to founder mutations that trace back many generations. The best-studied example involves Iranian Jewish and Moroccan Jewish communities. A study screening the ABCC2 gene in these groups found that all 22 Iranian Jewish patients tested were homozygous for the same I1173F mutation in exon 25, and carrier frequency in the general Iranian Jewish population was about 6 percent. A different mutation, R1150H, accounted for all five Moroccan Jewish cases, with a carrier rate of roughly 2 percent in the general Moroccan Jewish population. Neither mutation appeared in the other community or in Ashkenazi Jewish individuals tested.10Journal of Biological Chemistry. Identification and Functional Analysis of Two Novel Mutations in the Multidrug Resistance Protein 2 Gene in Israeli Patients with Dubin-Johnson Syndrome – Section: RESULTS
These population-specific mutations are considered founder effects, meaning they originated in a single ancestor and became relatively common through genetic drift in a small, historically isolated community. Ancestral age estimates for these mutations align with known ancient migration patterns of Jewish communities, supporting the idea that the mutations traveled with the populations as they dispersed.11PubMed. Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations Outside these groups, Dubin-Johnson syndrome has been reported in virtually every ethnic background, but no single mutation dominates. The condition is genuinely rare in most populations, with only scattered case reports in clinical literature.
When Dubin-Johnson Syndrome Appears in Newborns
Most textbooks describe Dubin-Johnson syndrome as first becoming apparent in adolescence or young adulthood, and that is the typical pattern. But it can occasionally present much earlier. Neonatal cholestasis, where a newborn develops jaundice with elevated conjugated bilirubin, is an important differential diagnosis because it triggers an extensive and sometimes invasive workup to rule out conditions like biliary atresia, which requires urgent surgery.12PubMed. Dubin-Johnson Syndrome as Differential Diagnosis for Neonatal Cholestasis – Section: OBJECTIVES
The neonatal presentation of Dubin-Johnson syndrome is rare, but recognizing it matters because the workup for neonatal cholestasis can include liver biopsy and even exploratory surgery. If genetic testing confirms ABCC2 mutations early, families can be spared the anxiety and children can avoid unnecessary procedures. The jaundice in these newborns typically resolves or becomes very mild as the infant grows, following the same benign course seen in older patients.
The Black Liver Problem in Surgery
One of the more unsettling scenarios involving Dubin-Johnson syndrome is what happens when a surgeon encounters the liver unexpectedly during an abdominal operation. The dramatic brownish-black discoloration of the liver can look alarming to a surgical team that has not been warned about the diagnosis. During procedures like laparoscopic gallbladder removal, the dark liver has been mistaken for a sign of biliary obstruction or a more serious liver disease, leading surgeons to expand the operation unnecessarily.
Case reports describe patients undergoing bile duct exploration and drainage tube placement for what turned out to be nothing more than the pigment deposition of Dubin-Johnson syndrome.13PubMed Central. Laparoscopic cholecystectomy for cholecystolithiasis with Dubin–Johnson syndrome – Section: Discussion These additional procedures carry real risks, including infection, bile leaks, and longer recovery times, all for a condition that needs no intervention. Chronic fluctuating jaundice can also lead to overtreatment if clinicians chase the elevated bilirubin with repeated imaging or invasive testing without considering a hereditary cause. The lesson for people with Dubin-Johnson syndrome is practical: make sure your surgical team knows your diagnosis before any abdominal procedure.
Overlapping with Gilbert Syndrome
Dubin-Johnson syndrome involves conjugated bilirubin, while Gilbert syndrome, the most common inherited jaundice, involves unconjugated bilirubin. Gilbert syndrome is caused by reduced activity of a different enzyme, one that attaches the sugar molecule to bilirubin in the first step of its processing. The two conditions affect different parts of the bilirubin pathway and are caused by mutations in different genes.14PubMed. Dual hereditary jaundice: simultaneous occurrence of mutations causing Gilbert’s and Dubin-Johnson syndrome
Because both are recessive conditions carried on separate genes, it is possible for one person to inherit both. When that happens, the blood work can be confusing: both conjugated and unconjugated bilirubin are elevated, and the clinical picture does not fit neatly into either diagnosis alone. Documented cases of dual hereditary jaundice exist, and genetic testing is the cleanest way to sort them out. The good news is that having both conditions does not change the favorable prognosis, since both are independently benign.
Life with Dubin-Johnson Syndrome
People with Dubin-Johnson syndrome generally live completely normal lives. The condition does not progress to liver cirrhosis, liver failure, or liver cancer. It does not shorten life expectancy.15PubMed Central. Dubin-Johnson Syndrome: A Case Report – Section: Abstract No specific treatment is needed, and no dietary restrictions are standard. Management is described in clinical literature as conservative, which in this context essentially means “do nothing medical.”
The real burden of the syndrome tends to be psychosocial rather than physical. Visible jaundice, even if mild, can draw questions and concern from others. Some people feel self-conscious about their yellowish eyes, especially during flare-ups triggered by illness or stress. Repeated medical encounters to investigate the jaundice before a diagnosis is established can also be draining. Once the diagnosis is confirmed, the most important practical steps are keeping a record of the diagnosis for future medical encounters and informing any new doctors or surgeons about it.
Women with the syndrome who become pregnant or consider hormonal contraception should be aware that estrogen can worsen jaundice temporarily. This does not mean pregnancy is dangerous or that oral contraceptives are absolutely prohibited, but the possibility of deeper jaundice during these times should be discussed with a physician so that it is not mistaken for a new liver problem when it occurs.
Animal Models and Research History
Dubin-Johnson syndrome was first described in 1954 by Isadore Dubin and Frank Johnson, who documented a series of patients with chronic jaundice and unidentified dark pigment in the liver.16PubMed. Dubin-Johnson Syndrome For decades, the cause was unknown. The molecular explanation only became clear in the 1990s when researchers identified the MRP2 protein and linked its absence to the syndrome.
Much of the early mechanistic work was done using mutant rat strains that spontaneously lack functional Mrp2, the rat equivalent of human MRP2. These rats develop conjugated hyperbilirubinemia and impaired bile transport, closely mirroring the human condition.17PubMed. Hepatic canalicular membrane 5: Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver The availability of these animal models allowed researchers to study how MRP2 works, what happens when it is absent, and how conjugated bilirubin and other organic compounds are handled by the liver. These models remain useful in pharmaceutical research because MRP2 is also involved in the excretion of many drugs, meaning that understanding its function has implications beyond Dubin-Johnson syndrome for predicting drug interactions and clearance in the liver.